The RSI Oscillator for SPRY moved out of oversold territory on September 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 28 of the 34 cases the stock moved higher. This puts the odds of a move higher at 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 55 cases where SPRY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for SPRY just turned positive on September 29, 2026. Looking at past instances where SPRY's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.
Following a +6.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRY advanced for three days, in 233 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRY as a result. In 79 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for SPRY entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SPRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (33.621) is normal, around the industry mean (2.978). P/E Ratio (-1.940) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (3.535) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TSHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 37 cases where TSHA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TSHA's RSI Oscillator exited the oversold zone, 31 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in 215 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for TSHA turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for TSHA moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TSHA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.315) is normal, around the industry mean (2.978). P/E Ratio (-9.610) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TSHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SPRY | TSHA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 50 | 50 | |
P/E GROWTH RATING 1..100 | 15 | 16 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TSHA's Valuation (23) in the null industry is significantly better than the same rating for SPRY (90). This means that TSHA’s stock grew significantly faster than SPRY’s over the last 12 months.
TSHA's Profit vs Risk Rating (100) in the null industry is in the same range as SPRY (100). This means that TSHA’s stock grew similarly to SPRY’s over the last 12 months.
TSHA's SMR Rating (98) in the null industry is in the same range as SPRY (100). This means that TSHA’s stock grew similarly to SPRY’s over the last 12 months.
TSHA's Price Growth Rating (50) in the null industry is in the same range as SPRY (50). This means that TSHA’s stock grew similarly to SPRY’s over the last 12 months.
SPRY's P/E Growth Rating (15) in the null industry is in the same range as TSHA (16). This means that SPRY’s stock grew similarly to TSHA’s over the last 12 months.
| SPRY | TSHA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 82% |
| Stochastic ODDS (%) | 2 days ago 78% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 87% | N/A |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 88% |
| Advances ODDS (%) | 13 days ago 82% | 29 days ago 81% |
| Declines ODDS (%) | 7 days ago 86% | 7 days ago 90% |
| BollingerBands ODDS (%) | N/A | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SPRY’s FA Score shows that 1 FA rating(s) are green while TSHA’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SPRY’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).
SPRY (@Biotechnology) experienced а +1.20% price change this week, while TSHA (@Biotechnology) price change was -4.83% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.23%. For the same industry, the average monthly price growth was -15.11%, and the average quarterly price growth was -14.93%.
SPRY is expected to report earnings on Nov 17, 2026.
TSHA is expected to report earnings on Nov 10, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.
| Ticker / NAME | Correlation To SPRY | 1D Price Change % | ||
|---|---|---|---|---|
| SPRY | 100% | +5.22% | ||
| LPCN - SPRY | 63% Loosely correlated | -1.92% | ||
| LXEO - SPRY | 41% Loosely correlated | +4.55% | ||
| TSHA - SPRY | 39% Loosely correlated | +8.84% | ||
| RYTM - SPRY | 36% Loosely correlated | +2.39% | ||
| KROS - SPRY | 35% Loosely correlated | +3.75% | ||
More | ||||
A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with MGTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To TSHA | 1D Price Change % | ||
|---|---|---|---|---|
| TSHA | 100% | +8.84% | ||
| MGTX - TSHA | 52% Loosely correlated | +1.83% | ||
| SLDB - TSHA | 52% Loosely correlated | +7.05% | ||
| STOK - TSHA | 52% Loosely correlated | +2.69% | ||
| ABEO - TSHA | 51% Loosely correlated | -0.45% | ||
| NGNE - TSHA | 49% Loosely correlated | +3.96% | ||
More | ||||